Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rigel Pharmaceuticals Inc (NASDAQ:RIGL)

2.51
Delayed Data
As of Feb 05
 -0.18 / -6.69%
Today’s Change
2.05
Today|||52-Week Range
5.20
-17.16%
Year-to-Date
No recent news for Rigel Pharmaceuticals Inc.

Today’s Trading

Previous close2.69
Today’s open2.69
Day’s range2.50 - 2.69
Volume447,850
Average volume (3 months)541,016
Market cap$222.2M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-1.96%
Earnings growth (this year)+45.19%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+15.38%
P/E ratioNM
Price/Sales24.12
Price/Book1.72

Competitors

 Today’s
change
Today’s
% change
NUTRNutraceutical Intern...-0.40-1.66%
CYTKCytokinetics Inc-0.33-4.56%
LJPCLa Jolla Pharmaceuti...-1.30-7.90%
CDTXCidara Therapeutics ...+0.01+0.09%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 1, 2016
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$8.3M
Annual profit (last year)-$90.9M
Net profit margin-1,101.92%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Raul R. Rodriguez
CFO, Executive VP &
Head-Investor Relations
Ryan D. Maynard
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers